Moderna, Alnylam settle patent row over COVID vaccine tech

Core Viewpoint - Moderna has reached an agreement to resolve patent litigation with Alnylam Pharmaceuticals regarding the delivery technology used in its COVID-19 vaccine, which Alnylam claimed infringed its patent rights [2]. Group 1 - The litigation involved allegations from Alnylam Pharmaceuticals against Moderna concerning the delivery technology utilized in the COVID-19 vaccine [2]. - Court filings indicate that the two companies have come to a resolution regarding the patent dispute [2].